Health Catalyst Stock Price, News & Analysis

Health Catalyst (Nasdaq: HCAT) has announced its participation in an upcoming investor conference. The company's leadership team, including Chief Executive Officer Dan Burton, Chief Financial Officer Jason Alger, and Chief Operating Officer Dan LeSueur, will attend the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event is scheduled to take place on February 11, 2025, in Snowbird, UT. Health Catalyst is known for providing data and analytics technology and services to healthcare organizations.

Modern Health has appointed Adam Brown as Chief Financial Officer, strengthening its executive team. Brown brings over fifteen years of healthcare finance experience, most recently serving as Senior VP of Financial Planning & Analysis and Investor Relations at Health Catalyst (NASDAQ: HCAT).

At Health Catalyst, Brown was instrumental in scaling the company from a venture-backed startup to a public company with over $300M in revenue and 1,400+ team members. He managed multiple funding rounds, including the company's IPO, and oversaw six acquisitions. His previous experience includes positions at GTCR's private equity healthcare practice and Bank of America Merrill Lynch's healthcare investment banking group.

The appointment follows Modern Health's recent developments, including a RAND Europe peer-reviewed study on global mental health support engagement and the acquisition of Anvil Health's AI technology.

Health Catalyst (Nasdaq: HCAT) has announced a multi-year partnership with OrthoNebraska, a leading orthopedic care provider based in Omaha, Nebraska. The partnership will leverage Health Catalyst's Ignite™ platform, a comprehensive data and analytics ecosystem designed to enhance patient outcomes, operational efficiency, and personalized patient experiences.

Ignite integrates clinical, financial, and patient experience data into a unified healthcare model, providing OrthoNebraska with a single access point for key performance indicators. This integration will enable OrthoNebraska to make more informed, data-driven decisions through self-service tools and enhanced analytics transparency.

OrthoNebraska's CEO, Levi Scheppers, emphasized that the partnership will simplify and personalize musculoskeletal healthcare by providing near real-time information to specialized teams. Health Catalyst will also offer ongoing operational support, including data source configuration, governance, and security administration.

Health Catalyst's CEO, Dan Burton, highlighted the importance of integrated data for improving patient outcomes and operational performance, noting that the Ignite platform is a scalable, long-term solution tailored for healthcare.

Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology and services, has been recognized as a leader in the 2024 Frost Radar™: US Population Health Management report by Frost & Sullivan. The company was praised for its innovative Population Health suite, which offers financial and quality benchmarking tools, administrative support, and advanced analytics.

Frost & Sullivan analysts evaluated over 50 US companies in the PHM market based on their innovation and growth strategies. Health Catalyst was highlighted for revolutionizing third-party PHM IT initiatives with custom configurations, a pre-built rules engine, and superior data management capabilities.

CEO Dan Burton emphasized the company's commitment to addressing healthcare challenges through innovation and client-centric solutions, contributing to value-based care. The report also noted Health Catalyst's strategic acquisitions of Carevive and Lumeon, enhancing its oncology care management and patient communication capabilities.

Industry Analyst Sagar Mukhekar commended Health Catalyst's balanced focus on growth and innovation, customized solutions, and superior data management, positioning it as a leader in the PHM market. The company's expansion into underserved segments further solidifies its leadership.

Health Catalyst (HCAT) has announced a strategic partnership with Databricks to enhance healthcare data sharing and analytics. The collaboration integrates Health Catalyst's Ignite™ platform with Databricks' Delta Sharing technology, creating a configurable solution specifically designed for healthcare organizations.

The partnership combines Health Catalyst's healthcare intelligence, including clinical, financial, operational, and regulatory expertise, with Databricks' technical infrastructure optimized for high-scale data processing. The joint solution leverages healthcare-specific data models and advanced analytics, enabling secure cross-platform data sharing across clouds and regions.

This integration aims to help healthcare organizations accelerate insights and access healthcare-ready data without building complex solutions from scratch, ultimately focusing on improving outcomes and operational efficiency.

Health Catalyst (HCAT) has announced a definitive agreement to acquire Upfront Healthcare Services, a next-generation patient engagement platform provider. The acquisition, expected to close in Q1 2025, will be funded through a mix of cash and stock.

The integration aims to combine Upfront's patient acquisition and scheduling expertise with Health Catalyst's existing patient engagement portfolio, including Twistle Patient Engagement and Lumeon Care Orchestration platform. Upfront's technology analyzes clinical, sociodemographic, and patient-reported data to guide patients to needed care, helping providers reengage patients, promote appointment attendance, and improve care transitions.

The merger will integrate with Health Catalyst Ignite™ Data and Analytics to enhance healthcare clients' ability to provide optimal patient care, focusing on optimizing access, improving care transitions, and closing care gaps.

Health Catalyst (Nasdaq: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's executive team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will be present.

The company's presentation is scheduled for Wednesday, January 15, 2025, at 10:30 am PT. Investors and interested parties can access the webcast and presentation materials through Health Catalyst's investor relations website at https://ir.healthcatalyst.com.

Health Catalyst (HCAT) announced the launch of an AI-powered version of BluePrint Protect™, following their agreement to acquire Intraprise Health. The platform helps healthcare organizations screen cybersecurity risks through third parties. The new AI-powered capability automates vendor security assessments, evaluation, and risk tracking, making the process more efficient and cost-effective.

The platform received the highest rating in a KLAS Emerging Company Spotlight Report with A+ scores across multiple categories. Key features include automated risk workflows, enhanced risk visibility through intuitive dashboards, customizable solutions, and compatibility with third-party products.

Health Catalyst (HCAT) has announced its leadership team's participation in three major upcoming investor conferences in December 2024. The schedule includes appearances at:

• The Citi 2024 Global Healthcare Conference in Miami on December 3 at 2:30 pm ET
• The 7th Annual Evercore HealthCONx Conference in Miami on December 4 at 2:10 pm ET
• The 36th Annual Piper Sandler Healthcare Conference in New York on December 5 at 12:30 pm ET